Li Yan Khor

648 total citations
36 papers, 470 citations indexed

About

Li Yan Khor is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Li Yan Khor has authored 36 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Li Yan Khor's work include Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Renal cell carcinoma treatment (3 papers). Li Yan Khor is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Renal cell carcinoma treatment (3 papers). Li Yan Khor collaborates with scholars based in Singapore, United States and Canada. Li Yan Khor's co-authors include Alan Pollack, Howard M. Sandler, William U. Shipley, Tahseen Al‐Saleem, Gerald E. Hanks, Michelle DeSilvio, V. Venkatesan, Mack Roach, C.A. Lawton and Elizabeth H. Hammond and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Li Yan Khor

33 papers receiving 462 citations

Peers

Countries citing papers authored by Li Yan Khor

Since Specialization

Citations

This map shows the geographic impact of Li Yan Khor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Yan Khor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Yan Khor more than expected).

Fields of papers citing papers by Li Yan Khor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Yan Khor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Yan Khor. The network helps show where Li Yan Khor may publish in the future.

Co-authorship network of co-authors of Li Yan Khor

This figure shows the co-authorship network connecting the top 25 collaborators of Li Yan Khor. A scholar is included among the top collaborators of Li Yan Khor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Yan Khor. Li Yan Khor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deep learning model for automated detection of Helicobacter pylori and intestinal metaplasia on gastric biopsy digital whole slide images 2025 ·American Journal of Clinical Pathology ·Li Yan Khor, (unknown), (unknown), (unknown), (unknown), Elaine Lum, (unknown), (unknown), Valerie Cui Yun Koh, Jeffrey Seow, (unknown), Ruoyu Shi, Shihleone Loong, (unknown), Anand Natarajan, (unknown), Kevin Oh, Chee Leong Cheng	0
2	Will artificial intelligence (AI) replace cytopathologists: a scoping review of current applications and evidence of A.I. in urine cytology 2025 ·World Journal of Urology ·(unknown), Tsung Wen Chong, Khi Yung Fong, Bo Han, Si Ying Tan, (unknown), Li Yan Khor, (unknown), Thomas Herrmann, Vineet Gauhar, (unknown), (unknown), Ee Jean Lim	1
3	346P High genomic risk is associated with clinically significant prostate cancer (csPCa) recurrences following focal therapy (FT) 2024 ·Annals of Oncology ·(unknown), Kae Jack Tay, Enya H.W. Ong, (unknown), Yu Guang Tan, Yan Mee Law, Nye Thane Ngo, Puay Hoon Tan, J.S.P. Yuen, Henry Sun Sien Ho, Ke Chen, (unknown), Jeffrey Tuan, (unknown), A. Lister, J. Proudfoot, (unknown), Li Yan Khor, Melvin L.K. Chua	1
4	Improving the accuracy of reporting Ki-67 IHC by using an AI tool 2024 ·Heliyon ·(unknown), (unknown), (unknown), (unknown), (unknown), Kaveh Taghipour, (unknown), Li Yan Khor, Kiat Hon Lim, Sathiyamoorthy Selvarajan, (unknown), (unknown), (unknown), (unknown)	0
5	Training immunophenotyping deep learning models with the same-section ground truth cell label derivation method improves virtual staining accuracy 2024 ·Frontiers in Immunology ·(unknown), (unknown), Juha P. Väyrynen, Willa Wen‐You Yim, (unknown), (unknown), Jeffrey Chun Tatt Lim, (unknown), Daniel S.W. Tan, Angela Takano, Chun Yuen Chow, Li Yan Khor, Tony Kiat Hon Lim, Joe Yeong, Mai Chan Lau, Yiyu Cai	1
6	Patient‐reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy‐monitored study 2023 ·The Prostate ·Yu Guang Tan, Yan Mee Law, Nye Thane Ngo, Li Yan Khor, Puay Hoon Tan, Enya H.W. Ong, J.S.P. Yuen, Henry Sun Sien Ho, Jeffrey Tuan, Ravindran Kanesvaran, Rajan T. Gupta, Steve Rozen, Melvin L.K. Chua, Thomas J. Polascik, Kae Jack Tay	9
7	A single tertiary institution review of the international system for serous fluid cytopathology and the impact of cell block and ancillary studies on its performance 2022 ·Journal of the American Society of Cytopathology ·(unknown), (unknown), Xin Cheng, Jacqueline Siok Gek Hwang, (unknown), (unknown), Angela Takano, Rehena Sultana, Li Yan Khor	4
8	Biomarkers for Precision Urothelial Carcinoma Diagnosis: Current Approaches and the Application of Single-Cell Technologies 2021 ·Cancers ·Michelle Hong, George He, Siting Goh, (unknown), Kae Jack Tay, Tony Kiat Hon Lim, (unknown), Joe Yeong, Li Yan Khor, Tong Seng Lim	19
9	Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer 2021 ·Frontiers in Immunology ·Chun Jye Lim, Phuong H. D. Nguyen, Martin Wasser, Pavanish Kumar, Yun Hua Lee, (unknown), Camillus Chua, Liyun Lai, Sharifah Nur Hazirah, (unknown), Li Yan Khor, Joe Yeong, Tony Kiat Hon Lim, (unknown), Salvatore Albani, Tsung Wen Chong, Valerie Chew	41
10	IgG4-Related Disease of the Thyroid Gland Requiring Emergent Total Thyroidectomy: A Case Report 2018 ·Head and Neck Pathology ·(unknown), Y.-J. Lee, Shuwei Zheng, Li Yan Khor, (unknown)	6
11	Multiparametric MRI reporting using Prostate Imaging Reporting and Data System version 2.0 (PI-RADSv2) retains clinical efficacy in a predominantly post-biopsy patient population 2018 ·Asian journal of urology ·(unknown), Yan Mee Law, Puay Hoon Tan, John Carson Allen, Lionel Tim‐Ee Cheng, (unknown), Li Yan Khor, Benjamin Y. Tan, (unknown), Christopher Wai Sam Cheng, John Shyi Peng Yuen, Henry Sun Sien Ho, Lui Shiong Lee	3
12	Gleason grade grouping of prostate cancer is of prognostic value in Asian men 2017 ·Journal of Clinical Pathology ·Joe Yeong, Rehena Sultana, (unknown), Hong Hong Huang, J.S.P. Yuen, Puay Hoon Tan, Li Yan Khor	12
13	Spindle Cell Lipoma in an End-Stage Renal Allograft: Case Report 2016 ·Transplantation Proceedings ·(unknown), Sathiyamoorthy Selvarajan, (unknown), Tse Hui Lim, Li Yan Khor	2
14	Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer 2016 ·JNCI Journal of the National Cancer Institute ·Alan Pollack, Deukwoo Kwon, Gail Walker, Li Yan Khor, Eric M. Horwitz, Mark K. Buyyounouski, Radka Stoyanova	6
15	Diagnostic Biomarkers in Eosinophilic Renal Neoplasms 2015 ·Urologic Clinics of North America ·Li Yan Khor, Puay Hoon Tan	2
16	Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer 2012 ·The Prostate ·Michael G. Heckman, Alexander S. Parker, Kevin J. Wu, (unknown), Stephen Ko, Thomas M. Pisansky, Steven E. Schild, Li Yan Khor, Elizabeth H. Hammond, Alan Pollack, Steven J. Buskirk	7
17	PKA knockdown enhances cell killing in response to radiation and androgen deprivation 2010 ·International Journal of Cancer ·Harvey H. Hensley, Jean‐Michel Hannoun‐Lévi, Paul Hachem, Zhaomei Mu, Radka Stoyanova, Li Yan Khor, Sudhir Agrawal, Alan Pollack	17
18	Evaluation of Ki-67 Staining Levels as an Independent Biomarker of Biochemical Recurrence After Salvage Radiation Therapy for Prostate Cancer 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Alexander S. Parker, Michael G. Heckman, Kevin J. Wu, Julia E. Crook, (unknown), Thomas M. Pisansky, (unknown), Steven E. Schild, Li Yan Khor, Elizabeth H. Hammond, Alan Pollack, Steven J. Buskirk	17
19	Activated STAT3 as a Correlate of Distant Metastasis in Prostate Cancer: A Secondary Analysis of Radiation Therapy Oncology Group 86-10 2007 ·Urology ·Javier F. Torres–Roca, Michelle DeSilvio, Linda Mora, Li Yan Khor, Elizabeth Hammond, Nazeel Ahmad, Richard Jove, Jeffrey D. Forman, (unknown), Howard M. Sandler, Alan Pollack	28
20	Bcl-2 and Bax Expression Predict Prostate Cancer Outcome in Men Treated with Androgen Deprivation and Radiotherapy on Radiation Therapy Oncology Group Protocol 92-02 2007 ·Clinical Cancer Research ·Li Yan Khor, Jennifer Moughan, Tahseen Al‐Saleem, Elizabeth H. Hammond, Varagur Venkatesan, Seth A. Rosenthal, Mark A. Ritter, Howard M. Sandler, Gerald E. Hanks, William U. Shipley, Alan Pollack	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact